DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tesofensine is an investigational drug.
There have been 10 clinical trials for Tesofensine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2003.
The most common disease conditions in clinical trials are Obesity, Diabetes Mellitus, and Body Weight. The leading clinical trial sponsors are Saniona, NeuroSearch A/S, and Boehringer Ingelheim.
Recent Clinical Trials for Tesofensine
|48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)||Saniona||Phase 2|
|A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate||Saniona||Phase 1|
|Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)||Saniona||Phase 2|